Gaucher Disease, Type II Recruiting Phase 1 Trials for Elosulfase alfa (DB09051)

Back to Gaucher Disease, Type II

Also known as: Type II Gaucher Disease / Gaucher's disease type II / Gaucher Disease, Type 2 / Type 2 Gaucher Disease / Acute neuronopathic Gaucher's disease (disorder)

Indication	Status	Phase
DBCOND0117120 (Gaucher Disease, Type II)	Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04532047	In Utero Enzyme Replacement Therapy for Lysosomal Storage Diseases	Treatment	Alglucosidase alfa (DB01272) Elosulfase alfa (DB09051) Galsulfase (DB01279) Idursulfase (DB01271) Laronidase (DB00090) Sebelipase alfa (DB11563) Vestronidase alfa (DB12366)